Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

about

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

Item

http://www.wikidata.org/entity/Q58750557

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

@en

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

@nl

type

Item

label

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

@en

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

@nl

prefLabel

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

@en

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

@nl

P1476

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9

@en

P2093

Chunyu Sheng

http://www.w3.org/2001/XMLSchema#string

Dongping Xu

http://www.w3.org/2001/XMLSchema#string

Hao Li

http://www.w3.org/2001/XMLSchema#string

Hongbin Song

http://www.w3.org/2001/XMLSchema#string

Hongbo Liu

http://www.w3.org/2001/XMLSchema#string

Jiangyun Zhao

http://www.w3.org/2001/XMLSchema#string

Jing Xie

http://www.w3.org/2001/XMLSchema#string

Lang Yang

http://www.w3.org/2001/XMLSchema#string

Leili Jia

http://www.w3.org/2001/XMLSchema#string

Ligui Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Measuring and Reducing Off-Target Activities of Programmable Nucleases Including CRISPR-Cas9

CRISPR-Cas9 knockin mice for genome editing and cancer modeling

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens

Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins.

In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni

In vivo genome editing using Staphylococcus aureus Cas9

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants.

Targeting Hepatitis B Virus With CRISPR/Cas9.

P304

2080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.02080

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30254645

http://www.w3.org/2001/XMLSchema#string

P921

CRISPR

P932

6141737

http://www.w3.org/2001/XMLSchema#string